Karen Pignet

Company: Lysogene

Job title: Executive Assistant to Founder & Chief Executive Officer

Seminars:

Encouraging Results in Young Children With MPSIIIA Following Intraparenchymal AAV Gene Therapy 1:30 pm

Delving into viral vector developments including the use of antibodies for facilitative transportation across the blood brain barrier Going beyond AAVs for neurological gene therapies Aiding in your viral vector selection with a greater understanding of choicesRead more

day: Clinical Stream Day 2 PM